GLNE 003: Preliminary Validation of Biomarkers Predictive of Barrett’s Esophagus Progression to Dysplasia and Adenocarcinoma

Abbreviated Name
GLNE 003: Preliminary Validation of Biomarkers Predictive of Barrett’s Esophagus Progression to Dysp
Lead Investigator
University of Michigan
Coordinating Investigator
No coordinating investigator
Involved Investigators

Abstact

No abstract availalbe.

Aims

Establish the feasibility of measuring the biomarkers in a multi-center clinical trial. 1.2   Estimate the variance of the biomarkers in cohorts defined by sex, race, age and histologic diagnosis (Barrett's intestinal metaplasia, Barrett's intestinal dysplasia [low-grade or high-grade], Adenocarcinoma, and non-Barrett’s controls). 1.3   Determine if the distributions of the biomarkers differ significantly among patients with different histologic diagnoses.

Analytic Method

No analytic method available.

Publications

  • No publications available at this time for this protocol.

Biomarkers

  • No biomarkers available at this time for this protocol.

Data Collections

  • No data collections available at this time for this protocol.
Finish Date
Jan 15 2009
Protocol ID
107
Protocol Type
Collaboration
Field of Research
Glycomics
Collaborative Group
G.I. and Other Associated Cancers Research Group
Cancer Types
  • Malignant neoplasm of esophagus

Associated Forms